ATLAS / Macro Radar / Reporting / BBOT

BridgeBio Oncology Therapeutics, Inc. (BBOT) reporting calendar

BridgeBio Oncology Therapeutics, Inc. files periodic reports with the SEC as BBOT on Nasdaq. Atlas tracks 9 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
26 Jul 2026 – 2 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
9

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open BBOT market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001193125-26-219829
10-K31 Dec 20255 Mar 202664 days0001193125-26-094112
10-Q30 Sep 202512 Nov 202543 days0001193125-25-277834
10-Q30 Jun 20251 Aug 202532 days0001213900-25-070659
10-Q31 Mar 202515 May 202545 days0001213900-25-044424
10-K31 Dec 202411 Mar 202570 days0001213900-25-022387
10-Q30 Sep 202414 Nov 202445 days0001213900-24-098483
10-Q30 Jun 202414 Aug 202445 days0001213900-24-068630
10-Q31 Mar 202415 May 202445 days0001213900-24-043582

Source: SEC EDGAR company submissions for CIK 0001869105. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.